Comparing T Cell Subsets in Broncho-Alveolar Lavage (BAL) and Peripheral Blood in Patients with Advanced Lung Cancer

Cells. 2022 Oct 14;11(20):3226. doi: 10.3390/cells11203226.

Abstract

Background: Lung cancer (LC) tissue for immunological characterization is often scarce. We explored and compared T cell characteristics between broncho-alveolar lavage from tumor affected (t-BAL) and contralateral lung (cl-BAL), with matched peripheral blood (PB).

Methods: BAL and PB were collected during bronchoscopy for diagnostic and/or therapeutic purposes in patients with monolateral primary lesion.

Results: Of 33 patients undergoing BAL and PB sampling, 21 had histologically-confirmed LC. Most cases were locally-advanced or metastatic non-small cell LC. T cell characteristics were not significantly different in t-BAL vs. cl-BAL. Compared to PB, CD8 T cells in BAL presented features of immune activation and exhaustion (high PD-1, low IFN-g production). Accordingly, regulatory CD4 T cells were also higher in BAL vs. PB. When dichotomizing T cell density in t-BAL in high and low, we found that PD-L1 expression in LC was associated with T cell density in t-BAL. T-BAL with high T cell density had higher %IFN-g+CD8 T cells and lower %T-regs.

Conclusion: In BAL from advanced LC patients, T cells present features of exhaustion. T cells in t-BAL could be the best surrogate of tumor-infiltrating T cell, and future studies should evaluate T cell phenotype and density as potential biomarkers for cancer immunotherapy outcome.

Keywords: BAL; PD-1; T cell; immunology; lung cancer.

MeSH terms

  • B7-H1 Antigen / metabolism
  • Bronchoalveolar Lavage Fluid
  • Humans
  • Interferon-gamma / metabolism
  • Lung Neoplasms* / immunology
  • Programmed Cell Death 1 Receptor / metabolism
  • T-Lymphocyte Subsets* / immunology

Substances

  • B7-H1 Antigen
  • Interferon-gamma
  • Programmed Cell Death 1 Receptor

Grants and funding

This research received no external funding.